Literature DB >> 11990733

Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training.

D R Woods1, M World, M P Rayson, A G Williams, M Jubb, Y Jamshidi, M Hayward, D A S G Mary, S E Humphries, H E Montgomery.   

Abstract

Human physical performance is strongly influenced by genetic factors. We have previously reported that the I variant of the human angiotensin I-converting enzyme (ACE) gene is associated with greater endurance performance in mountaineers and Olympic runners and improved performance in army recruits. In this study we examined whether this effect is mediated by improvements in cardiovascular fitness with training in 58 army recruits homozygous for the insertion (I, ACE genotype II) or deletion (D, ACE genotype DD) allele. A submaximal and maximal exercise protocol was used to calculate both the heart rate/oxygen uptake (VO2) relationship and changes in maximal oxygen uptake (VO2max), respectively. There was no significant intergroup difference in VO2max at baseline (P=0.19) or after training (P=0.22). There was no difference between genotypes with training in the heart rate/VO2 elevation (P = 0.79 for the mean difference in mean adjusted heart rates). However, VO2 at all exercise intensities in the submaximal test was lower for all subjects after training and at 80 W the reduction in VO2 was greater for the II subjects compared to DD subjects [mean(SEM)] [1.6 (0.27) and 0.68 (0.27) ml kg(-1) min(-1), respectively; P = 0.02 for mean difference]. The I/D polymorphism may play a role in enhanced endurance performance but this is not mediated by differences in VO2max or the heart rate/VO2 relationship in response to training.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11990733     DOI: 10.1007/s00421-001-0545-5

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  17 in total

Review 1.  Movement systems as dynamical systems: the functional role of variability and its implications for sports medicine.

Authors:  Keith Davids; Paul Glazier; Duarte Araújo; Roger Bartlett
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  A framework for understanding the training process leading to elite performance.

Authors:  David J Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 3.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

Review 4.  Association of genetic factors with selected measures of physical performance.

Authors:  William R Thompson; Stuart A Binder-Macleod
Journal:  Phys Ther       Date:  2006-04

5.  Association between ACE D allele and elite short distance swimming.

Authors:  Aldo Matos Costa; António José Silva; Nuno Domingos Garrido; Hugo Louro; Ricardo Jacó de Oliveira; Luiza Breitenfeld
Journal:  Eur J Appl Physiol       Date:  2009-05-21       Impact factor: 3.078

Review 6.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

7.  HIF1A P582S gene association with endurance training responses in young women.

Authors:  J S McPhee; J Perez-Schindler; H Degens; D Tomlinson; P Hennis; K Baar; A G Williams
Journal:  Eur J Appl Physiol       Date:  2011-02-23       Impact factor: 3.078

8.  No correlation between circulating ACE activity and VO2max or mechanical efficiency in women.

Authors:  Stephen H Day; Peter Gohlke; Sukhbir S Dhamrait; Alun G Williams
Journal:  Eur J Appl Physiol       Date:  2006-09-28       Impact factor: 3.078

9.  Performance at altitude and angiotensin I-converting enzyme genotype.

Authors:  G Tsianos; K I Eleftheriou; E Hawe; L Woolrich; M Watt; I Watt; A Peacock; H Montgomery; S Grant
Journal:  Eur J Appl Physiol       Date:  2004-12-01       Impact factor: 3.078

Review 10.  Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?

Authors:  Pei Wang; Matthew N Fedoruk; Jim L Rupert
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.